Literature DB >> 7916264

More questions than answers: antihistamines' link to cancer.

A Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7916264      PMCID： PMC1337135     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.

Authors:  J V Selby; G D Friedman; B H Fireman
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

2.  Between science and technology: the case of antihistamines and cancer.

Authors:  D L Weed
Journal:  J Natl Cancer Inst       Date:  1994-05-18       Impact factor: 13.506

3.  Initial screening for carcinogenicity of commonly used drugs.

Authors:  G D Friedman; H K Ury
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

4.  Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.

Authors:  L J Brandes; R J Arron; R P Bogdanovic; J Tong; C L Zaborniak; G R Hogg; R C Warrington; W Fang; F S LaBella
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

5.  Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents.

Authors:  L J Brandes; K J Simons; S P Bracken; R C Warrington
Journal:  J Clin Oncol       Date:  1994-06       Impact factor: 44.544

6.  H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450.

Authors:  F S LaBella; G Queen; G Glavin; G Durant; D Stein; L J Brandes
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

7.  Screening for possible drug carcinogenicity: second report of findings.

Authors:  G D Friedman; H K Ury
Journal:  J Natl Cancer Inst       Date:  1983-12       Impact factor: 13.506

8.  Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

Authors:  B Fisher; J P Costantino; C K Redmond; E R Fisher; D L Wickerham; W M Cronin
Journal:  J Natl Cancer Inst       Date:  1994-04-06       Impact factor: 13.506

9.  Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlates.

Authors:  L J Brandes; R C Warrington; R J Arron; R P Bogdanovic; W Fang; G M Queen; D A Stein; J Tong; C L Zaborniak; F S LaBella
Journal:  J Natl Cancer Inst       Date:  1994-05-18       Impact factor: 13.506
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.